Thank you, Bill, and good afternoon, everyone. I'll start by echoing those comments, we are extremely pleased with our record first quarter financial performance. I'll now dive into Q1 2024 financial results in more detail. Total revenue of $15.2 million represents a 54% increase from $9.9 million of revenue in Q1 2023. During the first quarter of 2024, we generated $3.4 million of revenue from the Blue Angels. Operating expenses for the 3 months ended March 31, 2024, were $15.1 million, including approximately $600,000 of depreciation and amortization and $1.8 million of amortization of capitalized production costs related to the Blue Angels compared to $12.5 million of operating expenses for the 3 months ended March 31, 2023, including approximately $500,000 of depreciation and amortization. Net loss for the quarter ended March 31, 2024, was approximately $300,000 and includes approximately $600,000 of depreciation and amortization and $1.8 million of amortization of capitalized production costs related to the Blue Angels and $500,000 of interest expense. This compares to the net loss of $3 million for the same period in 2023, which includes approximately $500,000 of depreciation and amortization, $400,000 of interest expense and $100,000 of equity losses in unconsolidated affiliates. Loss per share was $0.02 per share based on 18,477,825 weighted average shares outstanding for basic loss per share and 18,605,702 weighted average shares per fully diluted loss per share for the 3 months ended March 31, 2024. For the 3 months ended March 31, 2023, loss per share was $0.23 based on 12,640,285 weighted average shares outstanding for both basic and fully diluted loss per share. Cash and cash equivalents were $7.5 million as of March 31, 2024, compared to $7.6 million as of December 31, 2023. That concludes my financial remarks. I will now ask the operator to open the phone line for questions. Operator, would you please poll for questions?